TC-1 overexpression promotes cell proliferation in human non-small cell lung cancer that can be inhibited by PD173074

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Lei, Jie ^a   Li, Wenhai ^a   Yang, Ye ^b   Lu, Qiang ^a   Zhang, Na ^a   Bai, Guangzhen ^a   Zhong, Daixing ^a   Su, Kai ^a   Liu, Boya ^a   Li, Xiaofei ^a   Wang, Yunjie ^a   Wang, Xiaoping ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; CISPLATIN; ONCOPROTEIN; SHORT HAIRPIN RNA; THYROID CANCER 1 PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; C8ORF4 PROTEIN, HUMAN; PYRIMIDINE DERIVATIVE; SMALL INTERFERING RNA; TUMOR PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; AGED; ANIMAL; ANTAGONISTS AND INHIBITORS; CANCER TRANSPLANTATION; CARCINOMA, NON-SMALL-CELL LUNG; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME;

AGED; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PYRIMIDINES; RNA, SMALL INTERFERING; TUMOR BURDEN;

EID: 84903289523     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100075     Document Type: Article

References (23)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer Statistics, 2013. CA Cancer J Clin 63: 11-30.
2. Chua EL, Young L, Wu WM, Turtle JR, Dong Q (2000) Cloning of TC-1(C8orf4), a novel gene found to be overexpressed in thyroid cancer. Genomics 69: 342-347.
3. Sunde M, McGrath KC, Young L, Matthews JM, Chua EL, et al. (2004) TC-1 is a novel tumorigenic and natively disordered protein associated with thyroid cancer. Cancer Res 64: 2766-2773. (Pubitemid 38500614)
4. Gall C, Xu H, Brickenden A, Ai X, Choy WY (2007) The intrinsically disordered TC-l interacts with chibby via regions with high helical propensity. Protein Science 16: 2510-2518. (Pubitemid 350036756)
5. Kim Y, Kim J, Park J, Bang S, Jung Y, et al. (2006) TC1(C8orf4) is upregulated by IL-1β/TNF-α and enhances proliferation of human follicular dendritic cells. FEBS Lett 580: 3519-3524. (Pubitemid 43795901)
6. Wang YD, Bian GH, Lv XY, Zheng R, Sun H, et al. (2008) TC1 (C8orf4) is involved in ERK1/2 pathway-regulated G1- to S-phase transition. BMB reports 41: 733-738.
7. Kim B, Bang S, Lee S, Kim S, Jung Y, et al. (2004) Expression profiling and subtype-specific expression of stomach cancer. Cancer Res 63: 8248-8255.
8. Ray ME, Yang ZQ, Albertson D, Kleer CG, Washburn JG, et al. (2004) Genomic and expression analysis of the 8pl1-12 amplicon in human breast cancer cell lines. Cancer Res 64: 40-47. (Pubitemid 38114080)
9. Yang ZQ, Streicher KL, Ray ME, Abrams J, Ethier SP (2006) Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res 66: 11632-11643. (Pubitemid 46094174)
10. Jung Y, Bang S, Choi K, Kim E, Kim Y, et al. (2006) TC1 (C8orf4) Enhances the Wnt/β-catenin Pathway by Relieving Antagonistic Activity of Chibby. Cancer Res 66: 723-728. (Pubitemid 43165934)
11. Kim B, Koo H, Yang S, Bang S, Jung Y, et al. (2006) TC1 (C8orf4) Correlates with Wnt/β-Catenin Target Genes and Aggressive Biological Behavior in Gastric Cancer. Clin Cancer Res 12: 3541-3548.
12. Pardo OE, Latigo J, Jeffery RE, Nye E, Poulsom R, et al. (2009) The Fibroblast Growth Factor Receptor Inhibitor PD173074 Blocks Small Cell Lung Cancer Growth In vitro and In vivo. Cancer Res 69: 8645-8651.
13. Zhao J, Zhou Y, Zhang Z, Tian F, Ma N, et al. (2010) Upregulated fascin1 in non-small cell lung cancer promotes the migration and invasiveness, but not proliferation. Cancer Letters 290: 238-247.
14. Yang ZQ, Moffa AB, Haddad R, Streicher KL, Ethier EP (2007) Transforming properties of TC-1 in human breast cancer: Interaction with FGFR2 and β-catenin signaling pathways. Int. J. Cancer 121: 1265-1273. (Pubitemid 47293794)
15. Mohammadi M, Froum S, Hamby JM, Schroeder MC, Panek RL, et al. (1998) Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J 17: 5896-5904. (Pubitemid 28474784)
16. Ye YW, Hu S, Shi YQ, Zhang XF, Zhou Y, et al. (2013) Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer. Oncol Rep 30: 2777-2784.
17. Byron SA, Gartside MG, Wellens CL, Mallon MA, Keenan JB, et al. (2008) Inhibition of Activated Fibroblast Growth Factor Receptor 2 in Endometrial Cancer Cells Induces Cell Death Despite PTEN Abrogation. Cancer Res 68: 6902-6907.
18. Ye T, Wei X, Yin T, Xia Y, Li D, et al. (2014) Inhibition of FGFR signaling by PD 173074 improves antitumor immunity and impairs breast cancer metastasis. Breast Cancer Res Treat 143: 435-446.
19. Miyake M, Ishii M, Koyama N, Kawashima K, Kodama T, et al. (2010) 1-tert-Butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2, 3-d]pyrimidin-7-yl]-urea (PD173074), a Selective Tyrosine Kinase Inhibitor of Fibroblast Growth Factor Receptor-3 (FGFR3), Inhibits Cell Proliferation of Bladder Cancer Carrying the FGFR3 Gene Mutation along with Up-Regulation of p27/Kip1 and G1/G0 Arrest. The Journal of Pharmacology and Experimental Therapeutics 332: 795-802.
20. Nguyen PT, Tsunematsu T, Yanagisawa S, Kudo Y, Miyauchi M, et al. (2013) The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1. British Journal of Cancer 109: 2248-2258.
21. Lamont FR, Tomlinson DC, Cooper PA, Shnyder SD, Chester JD, et al. (2011) Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo. British Journal of Cancer 104: 75-82.
22. Traer E, Javidi-Sharifi N, Agarwal A, Dunlap J, English I, et al. (2014) Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations. Blood 123: 1516-1524.
23. Nallasamy S, Li Q, Bagchi MK, Bagchi IC (2012) Msx Homeobox Genes Critically Regulate Embryo Implantation by Controlling Paracrine Signaling between Uterine Stroma and Epithelium. PLoS Genet 8: e1002500.